Marla Davis v. HHS - Hepatitis B, transverse myelitis (2023)
Case summary [AI summaries can sometimes make mistakes]
Marla Davis filed a petition on February 23, 2018, alleging she suffered transverse myelitis (TM) as a result of a hepatitis B vaccine administered on August 13, 2015. She also received an influenza vaccine on September 21, 2015.
Ms. Davis alleged in the alternative that the flu and/or hepatitis B vaccine significantly aggravated her TM.
The respondent denied that the vaccines caused or aggravated her TM or any other injury. The parties reached a stipulation recommending an award of compensation.
The Special Master found the stipulation reasonable and adopted it. Ms.
Davis was awarded a lump sum of $192,000.00 as compensation for all damages available under the National Vaccine Injury Compensation Program. The judgment was entered in accordance with the stipulation.
Petitioner counsel was Bridget Candace McCullough of Muller Brazil, LLP, and respondent counsel was Jennifer Leigh Reynaud of the U.S. Department of Justice.
The Special Master was Nora Beth Dorsey.
Source PDFs
USCOURTS-cofc-1_18-vv-00283